Mechanisms of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid. In vivo studies.
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001831:Body Temperature / Q000187:drug effects; D003521:Cyclopropanes / Q000494:pharmacology*; D044943:Fatty Acid Desaturases / Q000378:metabolism; D005227:Fatty Acids / Q000097:blood; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007005:Hypoglycins / Q000494:pharmacology*; D008297:Male; D008660:Metabolism / Q000187:drug effects*; D051379:Mice; D008807:Mice, Inbred BALB C; D008930:Mitochondria, Liver / Q000187:drug effects / Q000378:metabolism; D010084:Oxidation-Reduction / Q000187:drug effects; D010421:Pentanoic Acids / Q000494:pharmacology*; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D014631:Valerates / Q000494:pharmacology*
D001786:Blood Glucose; D003521:Cyclopropanes; D005227:Fatty Acids; D007004:Hypoglycemic Agents; D007005:Hypoglycins; D010421:Pentanoic Acids; D011773:Pyruvates; D014631:Valerates; D044943:Fatty Acid Desaturases